Taiwan draws foreign biotech IPOs


Vibrant scene: Taiwan is home to the largest number of listed biotechnology companies in Asia with the sector expanding due to a well-educated workforce, historic appetite for high-tech industries and government support. – AFP

Singapore firm working on experimental cancer drugs plans listing by end-May

HONG KONG: A Singaporean biotechnology company working on experimental cancer drugs is listing in Taiwan, potentially opening the door for more foreign peers to go public on the island.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Business , IPO , cancer , drugs , Taiwan

Next In Business News

Ringgit likely to trade within narrow range next week ahead of BNM OPR decision
Reading the market signals
Urban harmony: Can stakeholders row together?
Breathing new life into forgotten spaces
FROM BANGSAR TO BEYOND
Asia to lead next AI wave
Luxury real estate trends in 2026
China’s gold rush continues
SC Estate Builder’s hotel acquisition under scrutiny
Department stores bet on experiences

Others Also Read